Co-Authors
This is a "connection" page, showing publications co-authored by Alessio Aghemo and Salvatore Badalamenti.
Connection Strength
0.559
-
Letter to the Editor: Clinical Management of Nonrespiratory Diseases in the COVID-19 Pandemic: What Have We Done and What Needs to Be Done? Telemed J E Health. 2020 10; 26(10):1206-1208.
Score: 0.221
-
The effect of COVID-19 epidemic on vital signs in hospitalized patients: a pre-post heat-map study from a large teaching hospital. J Clin Monit Comput. 2021 May 10.
Score: 0.059
-
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy. Int J Cardiol. 2021 02 01; 324:249-254.
Score: 0.057
-
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020 10; 106(19):1512-1518.
Score: 0.056
-
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. J Autoimmun. 2020 11; 114:102511.
Score: 0.056
-
High mortality in COVID-19 patients with mild respiratory disease. Eur J Clin Invest. 2020 Sep; 50(9):e13314.
Score: 0.056
-
Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
Score: 0.055